Piperazine, hexahydrate → Norfloxacin
Reaction equation
[CH2:1]([N:3]1[C:12]2[C:7](=[CH:8][C:9]([F:14])=[C:10](Cl)[CH:11]=2)[C:6](=[O:15])[C:5]([C:16]([OH:18])=[O:17])=[CH:4]1)[CH3:2].O.O.O.O.O.O.[NH:25]1[CH2:30][CH2:29][NH:28][CH2:27][CH2:26]1>>[CH2:1]([N:3]1[C:12]2[C:7](=[CH:8][C:9]([F:14])=[C:10]([N:25]3[CH2:30][CH2:29][NH:28][CH2:27][CH2:26]3)[CH:11]=2)[C:6](=[O:15])[C:5]([C:16]([OH:18])=[O:17])=[CH:4]1)[CH3:2]Participants
3
Procedure
A mixture of 1-ethyl-6-fluoro-7-chloro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (22g) and piperazine hexahydrate (160g) was heated at 135°-145° C. in an autoclave for 18.5 hr. The mixture was evaporated to dryness and dissolved in 10% sodium hydroxide. The solution was neutralized with acetic acid. The precipitate was collected, washed with water, dissolved in 30% acetic acid, and filtered. The filtrate was neutralized with 10% sodium hydroxide. The resulting precipitate was collected, washed with water and ethanol, and dried at 140°-145° C. in vacuo for 1.5 hr. to give 14g (54%) of 1-ethyl-6-fluoro-1,4-dihydro-7-(1-piperazinyl)-4-oxoquinoline-3-carboxylic acid (II) as colorless powder, m.p. 227°-228° C.
Workup
- temperaturewas heated at 135°-145° C. in an autoclave for 18.5 hr
- customThe mixture was evaporated to dryness
- dissolutiondissolved in 10% sodium hydroxide
- customThe precipitate was collected
- washwashed with water
- dissolutiondissolved in 30% acetic acid
- filtrationfiltered
- customThe resulting precipitate was collected
- washwashed with water and ethanol
- customdried at 140°-145° C. in vacuo for 1.5 hr
Sources & evidence
- ORD record
- ord-c5a7194b63064ce6804b8b7f1db8bd0e
- Source dataset
- uspto-grants-1979_03
- Patent number
- US04146719
Reaction notes
Loading…